Report Library
All ReportsDatamonitor Healthcare Oncology: Prostate Cancer Disease Coverage
June 01, 2018
Prostate cancer is a hormonally fueled disease, and the most common form of cancer found in males. Consequently, there is a high incentive
for drug development in this indication due to its large population size. While hormone-sensitive prostate cancer is well managed in terms of
treatment options, unmet need persists for patients with prostate cancer that is no longer responsive to hormonal manipulation. Newly
approved therapies for castration-resistant prostate cancer are set to create a shift in the way that the disease is treated, while creating a
competitive environment for new market entrants.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, Pricing & Reimbursement, and Pipeline modules.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, Pricing & Reimbursement, and Pipeline modules.
Indications Covered: | Prostate Cancer |